{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:00:14Z","timestamp":1787238014042,"version":"build-2736575974"},"reference-count":202,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>The thrombosis-related diseases are one of the leading causes of illness and death in the general population, and despite significant improvements in long-term survival due to remarkable advances in pharmacologic therapy, they continue to pose a tremendous burden on healthcare systems. The oxidative stress plays a role of pivotal importance in thrombosis pathophysiology. The anticoagulant and antiplatelet drugs commonly used in the management of thrombosis-related diseases show several pleiotropic effects, beyond the antithrombotic effects. The present review aims to describe the current evidence about the antioxidant effects of the oral antithrombotic therapies in patients with atherosclerotic disease and atrial fibrillation.<\/jats:p>","DOI":"10.3390\/antiox12061185","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T02:01:15Z","timestamp":1685498475000},"page":"1185","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Antioxidant Properties of Oral Antithrombotic Therapies in Atherosclerotic Disease and Atrial Fibrillation"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5669-574X","authenticated-orcid":false,"given":"Luigi","family":"Falco","sequence":"first","affiliation":[{"name":"Cardiology Unit, Department of Medical Translational Science, University of Campania \u201cLuigi Vanvitelli\u201d\u2014Monaldi Hospital, 80126 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Tessitore","sequence":"additional","affiliation":[{"name":"Cardiology Unit, Department of Medical Translational Science, University of Campania \u201cLuigi Vanvitelli\u201d\u2014Monaldi Hospital, 80126 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6919-899X","authenticated-orcid":false,"given":"Giovanni","family":"Ciccarelli","sequence":"additional","affiliation":[{"name":"Cardiology Unit, Department of Medical Translational Science, University of Campania \u201cLuigi Vanvitelli\u201d\u2014Monaldi Hospital, 80126 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5500-5533","authenticated-orcid":false,"given":"Marco","family":"Malvezzi","sequence":"additional","affiliation":[{"name":"Cardiology Unit, Department of Medical Translational Science, University of Campania \u201cLuigi Vanvitelli\u201d\u2014Monaldi Hospital, 80126 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9698-9145","authenticated-orcid":false,"given":"Antonello","family":"D\u2019Andrea","sequence":"additional","affiliation":[{"name":"Cardiology Unit, Umberto I Hospital, 84014 Nocera Inferiore, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2656-5467","authenticated-orcid":false,"given":"Egidio","family":"Imbalzano","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Golino","sequence":"additional","affiliation":[{"name":"Cardiology Unit, Department of Medical Translational Science, University of Campania \u201cLuigi Vanvitelli\u201d\u2014Monaldi Hospital, 80126 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9227-0360","authenticated-orcid":false,"given":"Vincenzo","family":"Russo","sequence":"additional","affiliation":[{"name":"Cardiology Unit, Department of Medical Translational Science, University of Campania \u201cLuigi Vanvitelli\u201d\u2014Monaldi Hospital, 80126 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Dubois-Deruy, E., Peugnet, V., Turkieh, A., and Pinet, F. (2020). Oxidative Stress in Cardiovascular Diseases. Antioxidants, 9.","DOI":"10.3390\/antiox9090864"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: The European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: Treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 Guideline for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack: A Guideline from the American Heart Association\/American Stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e000279","DOI":"10.1136\/openhrt-2015-000279","article-title":"NOACs versus warfarin for stroke prevention in patients with AF: A systematic review and meta-analysis","volume":"3","author":"Hicks","year":"2016","journal-title":"Open Heart"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jth.12485","article-title":"Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: A systematic review and meta-analysis","volume":"12","author":"Kooiman","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1016\/j.clinthera.2021.07.003","article-title":"Pharmacokinetics of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Extreme Obesity","volume":"43","author":"Russo","year":"2021","journal-title":"Clin. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"105317","DOI":"10.1016\/j.phrs.2020.105317","article-title":"Direct oral anticoagulants in the treatment of acute venous thromboembolism in patients with obesity: A systematic review with meta-analysis","volume":"163","author":"Mai","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0037-1607436","article-title":"Use of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Malignancy: Clinical Practice Experience in a Single Institution and Literature Review","volume":"44","author":"Russo","year":"2018","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-0038-1661386","article-title":"Atrial Fibrillation and Malignancy: The Clinical Performance of Non-Vitamin K Oral Anticoagulants-A Systematic Review","volume":"45","author":"Russo","year":"2019","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/FJC.0000000000000661","article-title":"Direct Oral Anticoagulants in Octogenarians with Atrial Fibrillation: It Is Never Too Late","volume":"73","author":"Russo","year":"2019","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"583311","DOI":"10.3389\/fphar.2020.583311","article-title":"Effectiveness and Safety of Oral Anticoagulants in Older Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis","volume":"11","author":"Grymonprez","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00228-022-03286-2","article-title":"Prevalence and clinical predictors of inappropriate direct oral anticoagulant dosage in octagenarians with atrial fibrillation","volume":"78","author":"Carbone","year":"2022","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11239-022-02740-3","article-title":"Clinical impact of oral anticoagulation among octogenarians with atrial fibrillation and anaemia","volume":"55","author":"Carbone","year":"2023","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e13335","DOI":"10.1111\/eci.13335","article-title":"Non-vitamin K vs vitamin K oral anticoagulants in patients aged >80 year with atrial fibrillation and low body weight","volume":"50","author":"Russo","year":"2020","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11239-019-01923-9","article-title":"Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: A multicentre propensity score matched real-world cohort study","volume":"49","author":"Russo","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1055\/s-0037-1615261","article-title":"Nonvitamin K Antagonist Oral Anticoagulants Use in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves\/Prior Surgical Valve Repair: A Multicenter Clinical Practice Experience","volume":"44","author":"Russo","year":"2018","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.clinthera.2019.10.008","article-title":"Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves","volume":"41","author":"Russo","year":"2019","journal-title":"Clin. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/1074248420935263","article-title":"Atrial Fibrillation and Mitral Regurgitation: Clinical Performance of Direct Oral Anticoagulants in a Real-World Setting","volume":"25","author":"Melillo","year":"2020","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/bph.13828","article-title":"Reactive oxygen species: Key regulators in vascular health and diseases","volume":"175","author":"Chen","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1089\/ars.2013.5607","article-title":"NADPH oxidases in vascular pathology","volume":"20","author":"Konior","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ncpcardio1211","article-title":"Oxidative stress in vascular disease: Causes, defense mechanisms and potential therapies","volume":"5","year":"2008","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/CIRCRESAHA.116.309326","article-title":"Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis","volume":"120","author":"Xia","year":"2017","journal-title":"Circ. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Martin-Ventura, J.L., Rodrigues-Diez, R., Martinez-Lopez, D., Salaices, M., Blanco-Colio, L.M., and Briones, A.M. (2017). Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18112315"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1172\/JCI200111927","article-title":"p47phox is required for atherosclerotic lesion progression in ApoE(\u2212\/\u2212) mice","volume":"108","author":"Patterson","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.112.132159","article-title":"NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis","volume":"127","author":"Gray","year":"2013","journal-title":"Circulation"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/01.ATV.0000040222.02255.0F","article-title":"Cytochrome b558-dependent NAD(P)H oxidase-phox units in smooth muscle and macrophages of atherosclerotic lesions","volume":"22","author":"Kalinina","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1161\/01.CIR.0000012917.74432.66","article-title":"Superoxide production and expression of nox family proteins in human atherosclerosis","volume":"105","author":"Sorescu","year":"2002","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Kleinschnitz, C., Grund, H., Wingler, K., Armitage, M.E., Jones, E., Mittal, M., Barit, D., Schwarz, T., Geis, C., and Kraft, P. (2010). Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol., 8.","DOI":"10.1371\/journal.pbio.1000479"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.jacc.2008.07.063","article-title":"Calcium- dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease","volume":"52","author":"Guzik","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbrc.2015.04.021","article-title":"Human monocytes and macrophages express NADPH oxidase 5; a potential source of reactive oxygen species in atherosclerosis","volume":"461","author":"Manea","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/01.ATV.0000196651.64776.51","article-title":"Coronary artery superoxide production and nox isoform expression in human coronary artery disease","volume":"26","author":"Guzik","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1161\/ATVBAHA.107.152629","article-title":"Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells","volume":"27","author":"Vendrov","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/01.ATV.0000258415.32883.bf","article-title":"Angiotensin II induces endothelial xanthine oxidase activation: Role for endothelial dysfunction in patients with coronary disease","volume":"27","author":"Landmesser","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1073\/pnas.93.16.8745","article-title":"Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits","volume":"93","author":"White","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/01.CIR.0000046448.26751.58","article-title":"Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers","volume":"107","author":"Guthikonda","year":"2003","journal-title":"Circulation"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.freeradbiomed.2006.03.026","article-title":"Xanthine oxidase inhibitor tungsten prevents the development of atherosclerosis in ApoE knockout mice fed a Western-type diet","volume":"41","author":"Vecchione","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: Regulation and function","volume":"33","author":"Sessa","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.coph.2013.01.006","article-title":"Uncoupling of endothelial NO synthase in atherosclerosis and vascular disease","volume":"13","author":"Li","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1124\/jpet.107.128009","article-title":"Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling","volume":"325","author":"Wohlfart","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.ATV.0000115637.48689.77","article-title":"Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP- cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice","volume":"24","author":"Alp","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1161\/CIRCULATIONAHA.107.704155","article-title":"Altered plasma versus vascular biopterins in human atherosclerosis reveal relationships between endothelial nitric oxide synthase coupling, endothelial function, and inflammation","volume":"116","author":"Antoniades","year":"2007","journal-title":"Circulation"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1161\/01.CIR.103.25.3099","article-title":"Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice","volume":"103","author":"Kuhlencordt","year":"2001","journal-title":"Circulation"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0355-7","article-title":"Mitochondrial dysfunction and oxidative stress in heart disease","volume":"51","author":"Peoples","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/01.CIR.0000023921.93743.89","article-title":"Mitochondrial integrity and function in atherogenesis","volume":"106","author":"Ballinger","year":"2002","journal-title":"Circulation"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.bbrc.2007.09.004","article-title":"Differential sensitivity to apoptosis among the cells that contribute to the atherosclerotic disease","volume":"363","author":"Zeini","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1161\/01.ATV.0000238347.77590.c9","article-title":"MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice","volume":"26","author":"Ohashi","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Masselli, E., Pozzi, G., Vaccarezza, M., Mirandola, P., Galli, D., Vitale, M., Carubbi, C., and Gobbi, G. (2020). ROS in Platelet Biology: Functional Aspects and Methodological Insights. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21144866"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000073600","article-title":"Oxidative stress in endothelial cell dysfunction and thrombosis","volume":"32","author":"Loscalzo","year":"2002","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1089\/1523086041361622","article-title":"The role of thiols and disulfides in platelet function","volume":"6","author":"Essex","year":"2004","journal-title":"Antioxid. Redox Signal."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/voxs.12331","article-title":"Role of red blood cells in haemostasis and thrombosis","volume":"12","author":"Litvinov","year":"2017","journal-title":"ISBT Sci. Ser."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1182\/blood-2012-05-427856","article-title":"Prothrombin activation in blood coagulation: The erythrocyte contribution to thrombin generation","volume":"120","author":"Whelihan","year":"2012","journal-title":"Blood"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.bpj.2010.12.3740","article-title":"Platelet adhesion from shear blood flow is controlled by near-wall rebounding collisions with erythrocytes","volume":"100","author":"Tokarev","year":"2011","journal-title":"Biophys. J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nature00804","article-title":"Subendothelial retention of atherogenic lipoproteins in early atherosclerosis","volume":"417","author":"Skalen","year":"2002","journal-title":"Nature"},{"key":"ref_60","first-page":"341","article-title":"Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats","volume":"113","author":"Joris","year":"1983","journal-title":"Am. J. Pathol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nm1102-1211","article-title":"Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime","volume":"8","author":"Steinberg","year":"2002","journal-title":"Nat. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/cvr\/cvx226","article-title":"Endothelial permeability, LDL deposition, and cardiovascular risk factors-a review","volume":"114","author":"Mundi","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1152\/physrev.00005.2003","article-title":"Role of monocytes in atherogenesis","volume":"83","author":"Osterud","year":"2003","journal-title":"Physiol. Rev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","article-title":"Immune and Inflammatory Mechanisms of Atherosclerosis","volume":"27","author":"Galkina","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1161\/ATVBAHA.112.300173","article-title":"Phenotypic polarization of macrophages in ath- erosclerosis","volume":"33","author":"Leitinger","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"31906","DOI":"10.1074\/jbc.M505568200","article-title":"Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state","volume":"280","author":"Potter","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"C21","DOI":"10.1152\/ajpcell.2000.279.1.C21","article-title":"H2O2-mediated permeability: Role of MAPK and occludin","volume":"279","author":"Kevil","year":"2000","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1073\/pnas.91.9.3619","article-title":"Redox regulation of signal transduction: Tyrosine phosphorylation and calcium influx","volume":"91","author":"Staal","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1172\/JCI27392","article-title":"NF-kappaB regulation of endothelial cell function during LPS-induced toxemia and cancer","volume":"116","author":"Kisseleva","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11883-017-0691-9","article-title":"Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target","volume":"19","author":"Mitra","year":"2017","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/01.CIR.101.13.1500","article-title":"Oxidized lipoproteins degrade the endothelial surface layer: Implications for platelet-endothelial cell adhesion","volume":"101","author":"Vink","year":"2000","journal-title":"Circulation"},{"key":"ref_73","first-page":"299","article-title":"Aortic endothelial cell proteoheparan sulfate. II. Modulation by extracellular matrix","volume":"128","author":"Keller","year":"1987","journal-title":"Am. J. Pathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"H1969","DOI":"10.1152\/ajpheart.01182.2008","article-title":"Patient-specific three- dimensional simulation of LDL accumulation in a human left coronary artery in its healthy and atherosclerotic states","volume":"296","author":"Olgac","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Wang, Q., and Zennadi, R. (2020). Oxidative Stress and Thrombosis during Aging: The Roles of Oxidative Stress in RBCs in Venous Thrombosis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124259"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm0196-35","article-title":"Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion","volume":"2","author":"Golino","year":"1996","journal-title":"Nat. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1161\/01.CIR.0000014611.28864.1E","article-title":"NADPH oxidase mediates tissue factor-dependent surface procoagulant activity by thrombin in human vascular smooth muscle cells","volume":"105","author":"Herkert","year":"2002","journal-title":"Circulation"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.freeradbiomed.2005.06.010","article-title":"Exogenous superoxide mediates pro-oxidative, proinflammatory, and procoagulatory changes in primary endothelial cell cultures","volume":"39","author":"Jacobi","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1538-7836.2008.03204.x","article-title":"Mitochondrial reactive oxygen species: A common pathway for PAR1- and PAR2-mediated tissue factor induction in human endothelial cells","volume":"7","author":"Banfi","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.freeradbiomed.2004.09.036","article-title":"The expression of the NADPH oxidase subunit p22phox is regulated by a redox-sensitive pathway in endothelial cells","volume":"38","author":"Djordjevic","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/1523086041361686","article-title":"Oxidized phospholipids in oxidized low-density lipoprotein reduce the activity of tissue factor pathway inhibitor through association with its carboxy-terminal region","volume":"6","author":"Ohkura","year":"2004","journal-title":"Antioxid. Redox Signal."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Gutmann, C., Siow, R., Gwozdz, A.M., Saha, P., and Smith, A. (2020). Reactive Oxygen Species in Venous Thrombosis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21061918"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1172\/JCI116151","article-title":"Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation","volume":"90","author":"Glaser","year":"1992","journal-title":"J. Clin. Investig."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"10268","DOI":"10.1074\/jbc.274.15.10268","article-title":"Oxidation of methionine residues in antithrombin. Effects on biological activity and heparin binding","volume":"274","author":"Hanson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1008859729045","article-title":"Prothrombotic Consequences of the Oxidation of Fibrinogen and their Inhibition by Aspirin","volume":"5","author":"Upchurch","year":"1998","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fphys.2012.00311","article-title":"Reactive oxygen species-targeted therapeutic interventions for atrial fibrillation","volume":"3","author":"Sovari","year":"2012","journal-title":"Front. Physiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tcm.2009.12.004","article-title":"Cardiac aging in mice and humans: The role of mitochondrial oxidative stress","volume":"19","author":"Dai","year":"2009","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.mehy.2008.08.031","article-title":"Oxidative stress: A possible pathogenesis of atrial fibrillation","volume":"72","author":"Huang","year":"2009","journal-title":"Med. Hypotheses."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2006.04.026","article-title":"The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation","volume":"115","author":"Korantzopoulos","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1046\/j.1460-9592.2003.t01-1-00234.x","article-title":"Electrophysiological Remodeling in Human Atrial Fibrillation","volume":"26","year":"2003","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.CIR.104.2.174","article-title":"Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation","volume":"104","author":"Mihm","year":"2001","journal-title":"Circulation"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/01.CIR.0000162461.67140.4C","article-title":"Defective cardiac ryanodine receptor regulation during atrial fibrillation","volume":"111","author":"Vest","year":"2005","journal-title":"Circulation"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/CIRCRESAHA.109.203836","article-title":"CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+ levels in right atrial myocardium of patients with atrial fibrillation","volume":"106","author":"Neef","year":"2010","journal-title":"Circ. Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/cvr\/cvq229","article-title":"Acute atrial arrhythmogenicity and altered Ca(2+) homeostasis in murine RyR2-P2328S hearts","volume":"89","author":"Zhang","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/CIRCRESAHA.112.273342","article-title":"Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia","volume":"111","author":"Shan","year":"2012","journal-title":"Circ. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.113.003313","article-title":"Oxidized CaMKII triggers atrial fibrillation","volume":"128","author":"Purohit","year":"2013","journal-title":"Circulation"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"11427","DOI":"10.1038\/srep11427","article-title":"Mitochondrial oxidative stress promotes atrial fibrillation","volume":"5","author":"Xie","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0014-5793(97)01307-0","article-title":"Aspirin protects endothelial cells from oxidative stress\u2014Possible synergism with vitamin E","volume":"417","author":"Podhaisky","year":"1997","journal-title":"FEBS Lett."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1161\/01.RES.82.9.1016","article-title":"Aspirin increases ferritin synthesis in endothelial cells: A novel antioxidant pathway","volume":"82","author":"Oberle","year":"1998","journal-title":"Circ. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0006-291X(03)01504-3","article-title":"Heme oxygenase-1 induction may explain the antioxidant profile of aspirin","volume":"308","author":"Grosser","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"18148","DOI":"10.1016\/S0021-9258(19)37165-0","article-title":"Ferritin: A cytoprotective antioxidant strategem of endothelium","volume":"267","author":"Balla","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_102","first-page":"782","article-title":"Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro","volume":"147","author":"Juckett","year":"1995","journal-title":"Am. J. Pathol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.3029864","article-title":"Bilirubin is an antioxidant of possible physiological importance","volume":"235","author":"Stocker","year":"1987","journal-title":"Science"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/jcmm.12812","article-title":"Aspirin induces Nrf2-mediated transcriptional activation of haem oxygenase-1 in protection of human melanocytes from H2O2-induced oxidative stress","volume":"20","author":"Jian","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/WNR.0000000000000969","article-title":"Aspirin suppresses neuronal apoptosis, reduces tissue inflammation, and restrains astrocyte activation by activating the Nrf2\/HO-1 signaling pathway","volume":"29","author":"Wang","year":"2018","journal-title":"Neuroreport"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/74680","article-title":"Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway","volume":"6","author":"Otterbein","year":"2000","journal-title":"Nat. Med."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0006-2952(00)00443-3","article-title":"Gene regulation of heme oxygenase-1 as a therapeutic target","volume":"60","author":"Immenschuh","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.canlet.2004.09.042","article-title":"Nrf2 as a novel molecular target for chemoprevention","volume":"224","author":"Lee","year":"2005","journal-title":"Cancer Lett."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Chen, C.M., Tung, Y.T., Wei, C.H., Lee, P.Y., and Chen, W. (2020). Anti-Inflammatory and Reactive Oxygen Species Suppression through Aspirin Pretreatment to Treat Hyperoxia-Induced Acute Lung Injury in NF-\u03baB-Luciferase Inducible Transgenic Mice. Antioxidants, 9.","DOI":"10.3390\/antiox9050429"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7150\/ijms.40959","article-title":"Action of low doses of Aspirin in Inflammation and Oxidative Stress induced by a\u03b21-42 on Astrocytes in primary culture","volume":"17","author":"Jorda","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"52729","DOI":"10.18632\/oncotarget.10400","article-title":"Activation of activator protein 2 alpha by aspirin alleviates atherosclerotic plaque growth and instability in vivo","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1023\/A:1006934612368","article-title":"Antioxidant properties of aspirin: Characterization of the ability of aspirin to inhibit silica-induced lipid peroxidation, DNA damage, NF-kappaB activation, and TNF-alpha production","volume":"199","author":"Shi","year":"1999","journal-title":"Mol. Cell. Biochem."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/107424840300800i109","article-title":"Suppression of oxidative stress as a mechanism of reduction of hypercholesterolemic atherosclerosis by aspirin","volume":"8","author":"Prasad","year":"2003","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"John, A., Amiri, L., Shafarin, J., Howarth, F.C., and Raza, H. (2021). Effect of Aspirin on Mitochondrial Dysfunction and Stress in the Pancreas and Heart of Goto-Kakizaki Diabetic Rats. Life, 11.","DOI":"10.3390\/life11090902"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"John, A., Amiri, L., Shafarin, J., Tariq, S., Adeghate, E., Howarth, F.C., and Raza, H. (2022). Alterations in Energy Metabolism, Mitochondrial Function and Redox Homeostasis in GK Diabetic Rat Tissues Treated with Aspirin. Life, 12.","DOI":"10.3390\/life12010104"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0009-2797(00)00168-X","article-title":"Preventive aspirin treatment of streptozotocin induced diabetes: Blockage of oxidative status and revertion of heme enzymes inhibition","volume":"126","author":"Caballero","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00001756-200202110-00009","article-title":"Aspirin inhibits stress-induced increase in plasma glutamate, brain oxidative damage and ATP fall in rats","volume":"13","author":"Madrigal","year":"2002","journal-title":"Neuroreport"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/jat.1638","article-title":"Effects of acetyl salycilic acid and ibuprofen in chronic liver damage induced by CCl4","volume":"32","author":"Shibayama","year":"2012","journal-title":"J. Appl. Toxicol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.biochi.2017.02.006","article-title":"Similar effect of sodium nitroprusside and acetylsalicylic acid on antioxidant system improvement in mouse liver but not in the brain","volume":"135","author":"Jurkowska","year":"2017","journal-title":"Biochimie"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/hc0302.102609","article-title":"Antioxidative properties of acetylsalicylic Acid on vascular tissues from normotensive and spontaneously hypertensive rats","volume":"105","author":"Wu","year":"2002","journal-title":"Circulation"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"761710","DOI":"10.1155\/2012\/761710","article-title":"Protective effects of aspirin from cardiac hypertrophy and oxidative stress in cardiomyopathic hamsters","volume":"2012","author":"Wu","year":"2012","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12031-011-9541-3","article-title":"Aspirin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity in primary midbrain cultures","volume":"46","author":"Wang","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/jnr.10851","article-title":"Antioxidant effect of acetylsalicylic and salicylic acid in rat brain slices subjected to hypoxia","volume":"75","author":"Guerrero","year":"2004","journal-title":"J. Neurosci. Res."},{"key":"ref_125","first-page":"51","article-title":"The Effects of Aspirin and Vitamin E on Blood Antioxidant Enzymes of Rats during Experimental Liver Ischemia-Reperfusion","volume":"1","author":"Eren","year":"2007","journal-title":"J. Appl. Biol. Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/ars.2011.4151","article-title":"Aspirin inhibits oxidant stress, reduces age-associated functional declines, and extends lifespan of Caenorhabditis elegans","volume":"18","author":"Ayyadevara","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1139\/cjpp-2017-0394","article-title":"Physiological and pharmacological inductors of HSP70 enhance the antioxidative defense mechanisms of the liver and pancreas in diabetic rats","volume":"96","author":"Dimitrovska","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Veres, G., Benke, K., Stengl, R., Bai, Y., Stark, K.A., Sayour, A.A., Radovits, T., Loganathan, S., Korkmaz-Ic\u00f6z, S., and Karck, M. (2022). Aspirin Reduces Ischemia-Reperfusion Injury Induced Endothelial Cell Damage of Arterial Grafts in a Rodent Model. Antioxidants, 11.","DOI":"10.3390\/antiox11020177"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Frydrychowski, P., Micha\u0142ek, M., Bil-Lula, I., Che\u0142mecka, E., Kafel, A., Noszczyk-Nowak, A., and Stygar, D. (2022). Cardioprotective Effect of Acetylsalicylic Acid in the Myocardial Ischemia-Reperfusion Model on Oxidative Stress Markers Levels in Heart Muscle and Serum. Antioxidants, 11.","DOI":"10.3390\/antiox11081432"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0006-291X(02)00271-1","article-title":"Aspirin potently inhibits oxidative DNA strand breaks: Implications for cancer chemoprevention","volume":"293","author":"Hsu","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1023\/A:1007867402152","article-title":"Effect of low-dose aspirin on the markers of oxidative stress","volume":"13","author":"Zilmer","year":"1999","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.clinbiochem.2009.10.054","article-title":"Effects of acetylsalicylic acid on serum paraoxonase activity, Ox-LDL, coenzyme Q10 and other oxidative stress markers in healthy volunteers","volume":"43","author":"Kurban","year":"2010","journal-title":"Clin. Biochem."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ejcts\/ezs591","article-title":"Acetylsalicylic acid treatment until surgery reduces oxidative stress and inflammation in patients undergoing coronary artery bypass grafting","volume":"43","author":"Berg","year":"2013","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e12273","DOI":"10.1111\/1755-5922.12273","article-title":"Endothelial damage effects of circulating microparticles from patients with stable angina are reduced by aspirin through ERK\/p38 MAPKs pathways","volume":"35","author":"Cheng","year":"2017","journal-title":"Cardiovasc. Ther."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2014.156","article-title":"Novel antiplatelet agents in acute coronary syndrome","volume":"12","author":"Franchi","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s40265-013-0126-z","article-title":"Pharmacology of the new P2Y12 receptor inhibitors: Insights on pharmacokinetic and pharmacodynamic properties","volume":"73","author":"Ferri","year":"2013","journal-title":"Drugs"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamainternmed.2018.0783","article-title":"Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008\u20132016","volume":"178","author":"Dayoub","year":"2018","journal-title":"JAMA Intern. Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e006275","DOI":"10.1161\/CIRCOUTCOMES.119.006275","article-title":"Physician and Hospital Utilization of P2Y12 Inhibitors in ST-Segment-Elevation Myocardial Infarction in the United States: A Study from the National Cardiovascular Data Registry\u2019s Research to Practice Initiative","volume":"13","author":"Faridi","year":"2020","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1620\/tjem.205.133","article-title":"Protective effects of clopidogrel on oxidant damage in a rat model of acute ischemia","volume":"205","author":"Kanko","year":"2005","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/path.2916","article-title":"Clopidogrel protects from cell apoptosis and oxidative damage in a mouse model of renal ischaemia-reperfusion injury","volume":"225","author":"Hu","year":"2011","journal-title":"J. Pathol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"790263","DOI":"10.1155\/2013\/790263","article-title":"Antiatherosclerotic potential of clopidogrel: Antioxidant and anti-inflammatory approaches","volume":"2013","author":"Hadi","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"9128050","DOI":"10.1155\/2016\/9128050","article-title":"Clopidogrel Protects Endothelium by Hindering TNF\u03b1-Induced VCAM-1 Expression through CaMKK\u03b2\/AMPK\/Nrf2 Pathway","volume":"2016","author":"Yang","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"e009600","DOI":"10.1161\/JAHA.118.009600","article-title":"Inhibition of Platelets by Clopidogrel Suppressed Ang II-Induced Vascular Inflammation, Oxidative Stress, and Remodeling","volume":"7","author":"An","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.arcmed.2020.05.003","article-title":"Clopidogrel Prophylaxis Abates Myocardial Ischemic Injury and Inhibits the Hyperlipidemia-Inflammation Loop in Hypercholestrolemic Mice","volume":"51","author":"Korish","year":"2020","journal-title":"Arch. Med. Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"9811","DOI":"10.12659\/MSM.917001","article-title":"Beneficial Effects of Ticagrelor on Oxidized Low-Density Lipoprotein (ox-LDL)-Induced Apoptosis in Human Umbilical Vein Endothelial Cells","volume":"25","author":"Kang","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"111488","DOI":"10.1016\/j.biopha.2021.111488","article-title":"Epac-1\/Rap-1 signaling pathway orchestrates the reno-therapeutic effect of ticagrelor against renal ischemia\/reperfusion model","volume":"139","author":"Abdallah","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.1038\/s41598-022-09627-6","article-title":"Cardioprotective effect of extracellular vesicles derived from ticagrelor-pretreated cardiomyocyte on hyperglycemic cardiomyocytes through alleviation of oxidative and endoplasmic reticulum stress","volume":"12","author":"Bitirim","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.thromres.2011.12.029","article-title":"Ticagrelor, but not clopidogrel and prasugrel, prevents ADP-induced vascular smooth muscle cell contraction: A placebo-controlled study in rats","volume":"130","author":"Grzesk","year":"2012","journal-title":"Thromb. Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/01.ATV.0000225288.74170.dc","article-title":"Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: Evidence for antioxidant and antiinflammatory effects","volume":"26","author":"Heitzer","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jsps.2011.01.006","article-title":"Beneficial effects of clopidogrel on glycemic indices and oxidative stress in patients with type 2 diabetes","volume":"19","author":"Taher","year":"2011","journal-title":"Saudi Pharm. J."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2017.06.099","article-title":"Prasugrel as opposed to clopidogrel improves endothelial nitric oxide bioavailability and reduces platelet-leukocyte interaction in patients with unstable angina pectoris: A randomized controlled trial","volume":"248","author":"Rudolph","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1160\/TH16-12-0973","article-title":"Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease","volume":"117","author":"Campo","year":"2017","journal-title":"Thromb. Haemost."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Aquila, G., Vieceli Dalla Sega, F., Marracino, L., Pavasini, R., Cardelli, L.S., Piredda, A., Scoccia, A., Martino, V., Fortini, F., and Bononi, I. (2020). Ticagrelor Increases SIRT1 and HES1 mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051576"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cca.2006.05.016","article-title":"Circulating endothelial cells: A novel marker of endothelial damage","volume":"373","author":"Erdbruegger","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.amjcard.2009.11.034","article-title":"Usefulness of clopidogrel to protect against diabetes-induced vascular damage","volume":"105","author":"McClung","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1160\/TH13-05-0394","article-title":"Clopidogrel results in favourable changes in nitric oxide metabolism in patients undergoing percutaneous coronary intervention","volume":"111","author":"Bundhoo","year":"2014","journal-title":"Thromb. Haemost."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11239-013-1019-4","article-title":"Factor-Xa inhibitors protect against systemic oxidant damage induced by peripheral-ischemia reperfusion","volume":"37","author":"Caliskan","year":"2014","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1475-2840-13-60","article-title":"Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression","volume":"13","author":"Ishibashi","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.thromres.2015.01.023","article-title":"Rivaroxaban inhibits oxidative and inflammatory reactions in advanced glycation end product-exposed tubular cells by blocking thrombin\/protease-activated receptor-2 system","volume":"135","author":"Ishibashi","year":"2015","journal-title":"Thromb. Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1159\/000431361","article-title":"Rivaroxaban Induces Mucosal Healing in a Rat Model of Trinitrobenzene Sulfonic Acid-Induced Colitis","volume":"24","author":"Erdal","year":"2015","journal-title":"Med. Princ. Pract."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.thromres.2016.04.008","article-title":"Expression of pro-inflammatory genes in human endothelial cells: Comparison of rivaroxaban and dabigatran","volume":"142","author":"Ellinghaus","year":"2016","journal-title":"Thromb. Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/hep.29084","article-title":"The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells","volume":"65","author":"Vilaseca","year":"2017","journal-title":"Hepatology"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000499975","article-title":"An Inhibitor of Activated Blood Coagulation Factor X Shows Anti-Endothelial Senescence and Anti-Atherosclerotic Effects","volume":"56","author":"Maeda","year":"2019","journal-title":"J. Vasc. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"113419","DOI":"10.1016\/j.fct.2022.113419","article-title":"Protective effects of rivaroxaban against cisplatin-induced testicular damage in rats: Impact on oxidative stress, coagulation, and p-NF-\u03baB\/VCAM-1 signaling","volume":"169","author":"Shafiey","year":"2022","journal-title":"Food Chem. Toxicol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00210-022-02319-y","article-title":"The protective effect of rivaroxaban with or without aspirin on inflammation, oxidative stress, and platelet reactivity in isoproterenol-induced cardiac injury in rats","volume":"396","author":"Abedalqader","year":"2023","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jphs.2018.07.002","article-title":"Factor Xa inhibition by rivaroxaban attenuates cardiac remodeling due to intermittent hypoxia","volume":"137","author":"Imano","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12012-019-09551-8","article-title":"Protective Effect of RIVA Against Sunitinib-Induced Cardiotoxicity by Inhibiting Oxidative Stress-Mediated Inflammation: Probable Role of TGF-\u03b2 and Smad Signaling","volume":"20","author":"Imam","year":"2020","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11239-020-02123-6","article-title":"Role of rivaroxaban in sunitinib-induced renal injuries via inhibition of oxidative stress-induced apoptosis and inflammation through the tissue nacrosis factor-\u03b1 induced nuclear factor-\u03baappa B signaling pathway in rats","volume":"50","author":"Imam","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"715354","DOI":"10.3389\/fphar.2021.715354","article-title":"Rivaroxaban Modulates TLR4\/Myd88\/NF-K\u03b2 Signaling Pathway in a Dose-Dependent Manner with Suppression of Oxidative Stress and Inflammation in an Experimental Model of Depression","volume":"12","author":"Abdelzaher","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1111\/bcp.13383","article-title":"FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms","volume":"83","author":"Serrano","year":"2017","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/FJC.0000000000001382","article-title":"Dual Pathway Inhibition with Rivaroxaban and Aspirin Reduces Inflammatory Biomarkers in Atherosclerosis","volume":"81","author":"Russo","year":"2023","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10557-020-07010-z","article-title":"Apixaban Downregulates Endothelial Inflammatory and Prothrombotic Phenotype in an In Vitro Model of Endothelial Dysfunction in Uremia","volume":"35","author":"Palomo","year":"2021","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Narita, Y., Hamamura, K., Kashiyama, M., Utsumi, S., Kakizoe, Y., Kondo, Y., Ishitsuka, Y., Jono, H., Irie, T., and Mukoyama, M. (2019). Edoxaban Exerts Antioxidant Effects Through FXa Inhibition and Direct Radical-Scavenging Activity. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20174140"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"e15218","DOI":"10.14814\/phy2.15218","article-title":"Factor Xa inhibitor, edoxaban ameliorates renal injury after subtotal nephrectomy by reducing epithelial-mesenchymal transition and inflammatory response","volume":"10","author":"Fang","year":"2022","journal-title":"Physiol. Rep."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10557-012-6411-3","article-title":"The beneficial effects of a direct thrombin inhibitor, dabigatran etexilate, on the development and stability of atherosclerotic lesions in apolipoprotein E-deficient mice: Dabigatran etexilate and atherosclerosis","volume":"26","author":"Kadoglou","year":"2012","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnagi.2013.00019","article-title":"Thrombin, a mediator of cerebrovascular inflammation in AD and hypoxia","volume":"5","author":"Tripathy","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5114\/aoms.2014.40742","article-title":"Thrombin inhibition by dabigatran attenuates atherosclerosis in ApoE deficient mice","volume":"10","author":"Pingel","year":"2014","journal-title":"Arch. Med. Sci."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/1076029615571629","article-title":"Comparison of Renoprotective Effect of Dabigatran with Low-Molecular-Weight Heparin","volume":"22","author":"Yazici","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_180","first-page":"580","article-title":"Effects of dabigatran regulates no-reflow phenomenon in acute myocardial infarction mice through anti-inflammatory and anti-oxidative activities and connective tissue growth factor expression","volume":"17","author":"Song","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Wo\u017aniak, E., Broncel, M., Bukowska, B., and Gorzelak-Pabi\u015b, P. (2020). The Protective Effect of Dabigatran and Rivaroxaban on DNA Oxidative Changes in a Model of Vascular Endothelial Damage with Oxidized Cholesterol. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21061953"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"116522","DOI":"10.1016\/j.lfs.2019.05.078","article-title":"Interruption of platelets and thrombin function as a new approach against liver fibrosis induced experimentally in rats","volume":"231","author":"Mahmoud","year":"2019","journal-title":"Life Sci."},{"key":"ref_183","first-page":"100862","article-title":"Short-term treatment with dabigatran alters protein expression patterns in a late-stage tau-based Alzheimer\u2019s disease mouse model","volume":"24","author":"Iannucci","year":"2020","journal-title":"Biochem. Biophys. Rep."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbrc.2020.04.068","article-title":"Inhibiting thrombin improves motor function and decreases oxidative stress in the LRRK2 transgenic Drosophila melanogaster model of Parkinson\u2019s disease","volume":"527","author":"Johnson","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5606\/tgkdc.dergisi.2022.22831","article-title":"Direct oral anticoagulant agents attenuate temporary aortic occlusion-induced renal oxidative and inflammatory responses in rats","volume":"30","author":"Durmaz","year":"2022","journal-title":"Turk. Gogus Kalp Damar Cerrahisi Derg."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Youssef, M.E., Abdel-Reheim, M.A., Morsy, M.A., El-Daly, M., Atwa, G.M.K., Yahya, G., Cavalu, S., Saber, S., and Ahmed Gaafar, A.G. (2022). Ameliorative Effect of Dabigatran on CFA-Induced Rheumatoid Arthritis via Modulating Kallikrein-Kinin System in Rats. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810297"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jare.2020.12.014","article-title":"Dabigatran mitigates cisplatin-mediated nephrotoxicity through down regulation of thrombin pathway","volume":"31","author":"Ewees","year":"2021","journal-title":"J. Adv. Res."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"173838","DOI":"10.1016\/j.ejphar.2020.173838","article-title":"A direct thrombin inhibitor, dabigatran etexilate protects from renal fibrosis by inhibiting protease activated receptor-1","volume":"893","author":"Saifi","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Russo, V., Attena, E., Baroni, M., Trotta, R., Manu, M.C., Kirchhof, P., and De Caterina, R. (2022). Clinical Performance of Oral Anticoagulants in Elderly with Atrial Fibrillation and Low Body Weight: Insight into Italian Cohort of PREFER-AF and PREFER-AF Prolongation Registries. J. Clin. Med., 11.","DOI":"10.3390\/jcm11133751"},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Carbone, A., Bottino, R., D\u2019Andrea, A., and Russo, V. (2023). Direct Oral Anticoagulants for Stroke Prevention in Special Populations: Beyond the Clinical Trials. Biomedicines, 11.","DOI":"10.3390\/biomedicines11010131"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/FJC.0000000000000786","article-title":"Update on Direct Oral Anticoagulants in Atrial Fibrillation Patients Undergoing Cardiac Interventional Procedures: From Clinical Trials to Real-World Evidence","volume":"75","author":"Melillo","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jacc.2021.06.012","article-title":"De-Escalation of Dual Antiplatelet Therapy in Patients with Acute Coronary Syndromes","volume":"78","author":"Shoji","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41569-022-00725-6","article-title":"P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention","volume":"19","author":"Capodanno","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Grze\u015bk, G., Rogowicz, D., Wo\u0142owiec, \u0141., Ratajczak, A., Gilewski, W., Chudzi\u0144ska, M., Sinkiewicz, A., and Banach, J. (2021). The Clinical Significance of Drug-Food Interactions of Direct Oral Anticoagulants. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168531"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Grze\u015bk, G., Wo\u017aniak-Wi\u015bniewska, A., B\u0142a\u017cejewski, J., G\u00f3rny, B., Wo\u0142owiec, \u0141., Rogowicz, D., and Nowaczyk, A. (2020). The Interactions of Nintedanib and Oral Anticoagulants-Molecular Mechanisms and Clinical Implications. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010282"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jacc.2013.07.104","article-title":"The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)","volume":"63","author":"Reilly","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/S0140-6736(14)61943-7","article-title":"Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: An analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial","volume":"385","author":"Ruff","year":"2015","journal-title":"Lancet"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"446","DOI":"10.5603\/AHP.a2021.0039","article-title":"Therapeutic monitoring of direct oral anticoagulants\u2014An 8-year observational study","volume":"52","year":"2021","journal-title":"Acta Haematol. Pol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jacc.2019.12.060","article-title":"Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial","volume":"75","author":"Zeitouni","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4081\/monaldi.2020.1224","article-title":"Edoxaban in elderly patient with morbid obesity and atrial fibrillation: The role of plasma levels evaluation for selecting the appropriate dose","volume":"90","author":"Russo","year":"2020","journal-title":"Monaldi Arch. Chest Dis."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1055\/s-0041-1723770","article-title":"Direct Oral Anticoagulants Plasma Levels Measurement: Clinical Usefulness from Trials and Real-World Data","volume":"47","author":"Renon","year":"2021","journal-title":"Semin. Thromb. Hemost."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/12\/6\/1185\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:45:12Z","timestamp":1760125512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/12\/6\/1185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":202,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["antiox12061185"],"URL":"https:\/\/doi.org\/10.3390\/antiox12061185","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]}}}